Goldman Sachs’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Sell |
278,736
-65,501
| -19% | -$2.86M | ﹤0.01% | 2129 |
|
|
2025
Q1 | $9.42M | Sell |
344,237
-89,707
| -21% | -$2.46M | ﹤0.01% | 2274 |
|
|
2024
Q4 | $17.5M | Buy |
433,944
+209,113
| +93% | +$8.41M | ﹤0.01% | 1894 |
|
|
2024
Q3 | $10.6M | Sell |
224,831
-237,478
| -51% | -$11.2M | ﹤0.01% | 2194 |
|
|
2024
Q2 | $13.8M | Buy |
462,309
+11,791
| +3% | +$352K | ﹤0.01% | 1848 |
|
|
2024
Q1 | $18.1M | Sell |
450,518
-224,137
| -33% | -$9.01M | ﹤0.01% | 1627 |
|
|
2023
Q4 | $17.2M | Buy |
674,655
+469,947
| +230% | +$12M | ﹤0.01% | 1679 |
|
|
2023
Q3 | $2.85M | Sell |
204,708
-136,837
| -40% | -$1.9M | ﹤0.01% | 2862 |
|
|
2023
Q2 | $7.85M | Buy |
341,545
+44,702
| +15% | +$1.03M | ﹤0.01% | 2230 |
|
|
2023
Q1 | $8.8M | Sell |
296,843
-41,087
| -12% | -$1.22M | ﹤0.01% | 2109 |
|
|
2022
Q4 | $8.43M | Buy |
337,930
+1,171
| +0.3% | +$29.2K | ﹤0.01% | 2249 |
|
|
2022
Q3 | $7.33M | Buy |
336,759
+59,495
| +21% | +$1.3M | ﹤0.01% | 2364 |
|
|
2022
Q2 | $5.46M | Buy |
277,264
+33,338
| +14% | +$656K | ﹤0.01% | 2588 |
|
|
2022
Q1 | $10.3M | Sell |
243,926
-23,864
| -9% | -$1.01M | ﹤0.01% | 2217 |
|
|
2021
Q4 | $17M | Buy |
267,790
+87,583
| +49% | +$5.56M | ﹤0.01% | 1886 |
|
|
2021
Q3 | $10.6M | Buy |
180,207
+100,204
| +125% | +$5.89M | ﹤0.01% | 2222 |
|
|
2021
Q2 | $3.88M | Buy |
80,003
+65,507
| +452% | +$3.18M | ﹤0.01% | 2976 |
|
|
2021
Q1 | $563K | Sell |
14,496
-13,434
| -48% | -$522K | ﹤0.01% | 4279 |
|
|
2020
Q4 | $1.73M | Sell |
27,930
-119,808
| -81% | -$7.43M | ﹤0.01% | 3145 |
|
|
2020
Q3 | $4.77M | Buy |
+147,738
| New | +$4.77M | ﹤0.01% | 2415 |
|